|
|
|
|
LEADER |
02399nam a2200313 u 4500 |
001 |
EB001897112 |
003 |
EBX01000000000000001060117 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
200523 r ||| eng |
020 |
|
|
|a 0309494885
|
020 |
|
|
|a 9780309494885
|
100 |
1 |
|
|a Alper, Joe
|
245 |
0 |
0 |
|a Virtual clinical trials
|h Elektronische Ressource
|b challenges and opportunities : proceedings of a workshop
|c Joe Alper, Eeshan Khandekar, and Carolyn Shore, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine
|
260 |
|
|
|a Washington, DC
|b National Academies Press
|c [2019], 2019
|
300 |
|
|
|a 1 PDF file (xxvii, 108 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a United States
|
653 |
|
|
|a Clinical Trials as Topic / methods
|
653 |
|
|
|a Virtual Reality
|
700 |
1 |
|
|a Khandekar, Eeshan
|e [rapporteur]
|
700 |
1 |
|
|a Shore, Carolyn
|e [rapporteur]
|
710 |
2 |
|
|a National Academies of Sciences, Engineering, and Medicine (U.S.)
|b Forum on Drug Discovery, Development, and Translation
|
710 |
2 |
|
|a Virtual Clinical Trials: Challenges and Opportunities (Workshop) (2018, Washington, D.C.)
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK544217
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a Successful drug development relies on accurate and efficient clinical trials to deliver the best and most effective pharmaceuticals and clinical care to patients. However, the current model for clinical trials is outdated, inefficient and costly. Clinical trials are limited by small sample sizes that do not reflect variations among patients in the real world, financial burdens on participants, and slow processes, and these factors contribute to the disconnect between clinical research and clinical practice. On November 28-29, the National Academies of Sciences, Engineering, and Medicine convened a workshop to investigate the current clinical trials system and explore the potential benefits and challenges of implementing virtual clinical trials as an enhanced alternative for the future. This publication summarizes the presentations and discussions from the workshop
|